🔎 Trials Near Me

Gara Jalqabaatti › Amyloidosis › Missouri › St. Louis

Qorannoo klinikaalii Amyloidosis St. Louis, MO keessatti

Qorannoo 6 Amyloidosis f St. Louis fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Research Site, St Louis
Umuriin 18 hanga 130 · Saalaa hunda · Haaromfame 23-Ful-2026 · NCT06465810

TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy

Namoota walitti qabaa jiraSadarkaa 3
  • Clinical Trial Site, St Louis
Umuriin 18 hanga 85 · Saalaa hunda · Haaromfame 16-Ful-2026 · NCT07052903

DemonsTTRate: A Global, Observational, Multicenter, Long-term Study of Patients With ATTR-CM in a Real-World Setting

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Clinical Trial Site, St Louis
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Ful-2026 · NCT07358078

Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

Namoota walitti qabaa jiraSadarkaa 3
  • Washington University in St. Louis, St Louis
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 04-Hag-2026 · NCT06563895

Cardiac Magnetic Resonance and Echocardiography Study With Acoramidis

Namoota walitti qabaa jiraSadarkaa 4
  • Washington University in St. Louis, St Louis
Umuriin 18 hanga 80 · Saalaa hunda · Haaromfame 29-Ado-2026 · NCT07695701

A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory AL Amyloidosis.

Namoota walitti qabaa jiraSadarkaa 1/2
  • Research Site, St Louis
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Ado-2026 · NCT07081646

Qorannoo Amyloidosis magaalota biroo keessatti

Qorannoo biroo St. Louis keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.